Asymchem Laboratories (Tianjin) Co., Ltd.
Asymchem Laboratories (Tianjin) Co., Ltd. Fundamental Analysis
Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK) shows weak financial fundamentals with a PE ratio of 30.68, profit margin of 16.51%, and ROE of 6.07%. The company generates $6.4B in annual revenue with weak year-over-year growth of -25.82%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 23.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 6821.HK's fundamental strength across five key dimensions:
Efficiency Score
Weak6821.HK struggles to generate sufficient returns from assets.
Valuation Score
Moderate6821.HK shows balanced valuation metrics.
Growth Score
Weak6821.HK faces weak or negative growth trends.
Financial Health Score
Excellent6821.HK maintains a strong and stable balance sheet.
Profitability Score
Moderate6821.HK maintains healthy but balanced margins.
Key Financial Metrics
Is 6821.HK Expensive or Cheap?
P/E Ratio
6821.HK trades at 30.68 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, 6821.HK's PEG of -11.48 indicates potential undervaluation.
Price to Book
The market values Asymchem Laboratories (Tianjin) Co., Ltd. at 1.84 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 31.36 times EBITDA. This signals the market has high growth expectations.
How Well Does 6821.HK Make Money?
Net Profit Margin
For every $100 in sales, Asymchem Laboratories (Tianjin) Co., Ltd. keeps $16.51 as profit after all expenses.
Operating Margin
Core operations generate 18.58 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $6.07 in profit for every $100 of shareholder equity.
ROA
Asymchem Laboratories (Tianjin) Co., Ltd. generates $5.24 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Asymchem Laboratories (Tianjin) Co., Ltd. produces operating cash flow of $1.18B, showing steady but balanced cash generation.
Free Cash Flow
Asymchem Laboratories (Tianjin) Co., Ltd. produces free cash flow of $287.07M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.80 in free cash annually.
FCF Yield
6821.HK converts 0.88% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
30.68
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-11.48
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.84
vs 25 benchmark
P/S Ratio
Price to sales ratio
5.13
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.02
vs 25 benchmark
Current Ratio
Current assets to current liabilities
6.37
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.06
vs 25 benchmark
ROA
Return on assets percentage
0.05
vs 25 benchmark
ROCE
Return on capital employed
0.06
vs 25 benchmark
How 6821.HK Stacks Against Its Sector Peers
| Metric | 6821.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 30.68 | 28.31 | Neutral |
| ROE | 6.07% | 699.00% | Weak |
| Net Margin | 16.51% | -130884.00% (disorted) | Strong |
| Debt/Equity | 0.02 | 0.34 | Strong (Low Leverage) |
| Current Ratio | 6.37 | 2775.16 | Strong Liquidity |
| ROA | 5.24% | -14469.00% (disorted) | Weak |
6821.HK outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Asymchem Laboratories (Tianjin) Co., Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
114.32%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
55.62%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
89.61%
Industry Style: Defensive, Growth, Innovation
High Growth